Suresh T. Chari mainly focuses on Internal medicine, Autoimmune pancreatitis, Pathology, Pancreatitis and Pancreatic cancer. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Diabetes mellitus. The study incorporates disciplines such as Inflammatory bowel disease, Immunology, Pancreatic mass, Obstructive jaundice and Serology in addition to Autoimmune pancreatitis.
Pathology and Pancreas are frequently intertwined in his study. His Pancreatitis study combines topics in areas such as Epidemiology, Jaundice, Pathogenesis, Acute pancreatitis and Pancreatic disease. His studies examine the connections between Pancreatic cancer and genetics, as well as such issues in Pancreatic duct, with regards to Carcinoma, Malignancy, Histology and Radiology.
Suresh T. Chari mostly deals with Internal medicine, Gastroenterology, Pancreatic cancer, Pancreatitis and Autoimmune pancreatitis. Suresh T. Chari works mostly in the field of Internal medicine, limiting it down to concerns involving Diabetes mellitus and, occasionally, Body mass index. His study ties his expertise on Primary sclerosing cholangitis together with the subject of Gastroenterology.
Suresh T. Chari has researched Pancreatic cancer in several fields, including Adenocarcinoma, Cancer research, Early detection and Risk factor. His study brings together the fields of Pancreatic disease and Pancreatitis. Suresh T. Chari's looking at Autoimmune pancreatitis as part of his Pathology and Disease and Autoimmune pancreatitis study.
His primary areas of study are Internal medicine, Pancreatic cancer, Gastroenterology, Diabetes mellitus and Oncology. His research ties Endocrinology and Internal medicine together. His work focuses on many connections between Pancreatic cancer and other disciplines, such as Pancreas, that overlap with his field of interest in Radiology and Convolutional neural network.
His Gastroenterology research integrates issues from Asymptomatic and Intraductal papillary mucinous neoplasm. His study in Pancreatitis focuses on Autoimmune pancreatitis in particular. His work is dedicated to discovering how Autoimmune pancreatitis, Rituximab are connected with IgG4-related disease and other disciplines.
Suresh T. Chari mainly investigates Internal medicine, Pancreatic cancer, Pancreatitis, Diabetes mellitus and Gastroenterology. His work carried out in the field of Pancreatic cancer brings together such families of science as Pancreatic cysts, Prospective cohort study, Cohort study and Oncology. His Pancreatitis research is multidisciplinary, relying on both Stage, Acute pancreatitis, Hepatitis and Pathology.
His research integrates issues of Relapse rate, Therapeutic strategy and Steroid therapy in his study of Pathology. His work on Type 2 diabetes, Adipokine and Diabetes obesity as part of general Diabetes mellitus research is frequently linked to High-density lipoprotein, thereby connecting diverse disciplines of science. His work in Gastroenterology addresses subjects such as Intraductal papillary mucinous neoplasm, which are connected to disciplines such as Pancreatic duct, Dysplasia, Surgical strategy and General surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Consensus statement on the pathology of IgG4-related disease
Vikram Deshpande;Yoh Zen;John Kc Chan;Eunhee E Yi.
Modern Pathology (2012)
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
Masao Tanaka;Carlos Fernández-Del Castillo;Volkan Adsay;Suresh Chari.
International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.
Masao Tanaka;Suresh Chari;Volkan Adsay;Carlos Fernandez-del Castillo.
International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology.
Tooru Shimosegawa;Suresh T. Chari;Luca Frulloni;Terumi Kamisawa.
Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience.
Suresh T. Chari;Thomas C. Smyrk;Michael J. Levy;Mark D. Topazian.
Clinical Gastroenterology and Hepatology (2006)
Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy
Amaar Ghazale;Suresh T. Chari;Lizhi Zhang;Thomas C. Smyrk.
International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease
A. Khosroshahi;Z. S. Wallace;J. L. Crowe;T. Akamizu.
Arthritis & Rheumatism (2015)
Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer.
Amaar Ghazale;Suresh T Chari;Thomas C Smyrk;Michael J Levy.
The American Journal of Gastroenterology (2007)
Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases
Kenji Notohara;Lawrence J. Burgart;Dhiraj Yadav;Suresh Chari.
The American Journal of Surgical Pathology (2003)
Probability of Pancreatic Cancer Following Diabetes: A Population-Based Study
Suresh T. Chari;Cynthia L. Leibson;Kari G. Rabe;Jeanine Ransom.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: